Abbott Laboratories buy Piper Sandler
Start price
17.04.25
/
50%
€116.00
Target price
17.04.26
€127.60
Performance (%)
-26.34%
Price
09:38
€85.44
This prediction will end soon
Summary
This prediction is currently active. The price of Abbott Laboratories has decreased since the start of the prediction. Compared to the start price this results in a performance of -26.34%. This prediction currently runs until 17.04.26. The prediction end date can be changed by Piper_Sandler at any time. Piper_Sandler has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Abbott Laboratories | -4.137% | -4.137% |
| iShares Core DAX® | 2,55 % | 0,56 % |
| iShares Nasdaq 100 | 2,74 % | -0,60 % |
| iShares Nikkei 225® | 6,58 % | 4,34 % |
| iShares S&P 500 | 1,93 % | -0,51 % |
Comments by Piper_Sandler for this prediction
In the thread Discuss Abbott Laboratories
Abbott Laboratories (NYSE: ABT) had its "overweight" rating re-affirmed by analysts at Piper Sandler. They now have a $145.00 price target on the stock, up previously from $133.00.
Ratings data for ABT provided by MarketBeat
Stopped prediction by Piper_Sandler for Abbott Laboratories
Abbott Laboratories
Start price
Target price
Perf. (%)
€93.02
23.01.26
23.01.26
€114.93
23.01.27
23.01.27
-8.26%
09:38
09:38
Abbott Laboratories
Start price
Target price
Perf. (%)
€109.48
17.10.24
17.10.24
€122.61
17.10.25
17.10.25
0.46%
18.10.25
18.10.25
Abbott Laboratories
Start price
Target price
Perf. (%)
€103.70
19.09.24
19.09.24
€117.72
19.09.25
19.09.25
12.09%
20.09.25
20.09.25